Medical cannabis certification via telehealth: state rules, payment models, and the COVID-era flexibilities that stuck around
Most US medical cannabis programs allow physician certification via telehealth. A few notable exceptions require in-person evaluations for initial certifications (Florida) or for specific patient categories. This is a state-by-state guide to telehealth certification, the federal flexibilities that govern controlled-substance prescribing, and the payment models patients should expect.
Before March 2020, medical cannabis certification was an in-person process in nearly every US state. A patient seeking a card had to physically present to a state-registered physician's office, undergo an evaluation, and receive the certification on paper. The visit cost ranged from $100 to $300 and required time off work, travel to a specialty office, and (often) a waiting list.
The COVID-era public health emergency changed that. Federal telemedicine flexibilities, paired with state-level temporary rules, opened cannabis certification to remote audio-video visits across nearly every medical-cannabis state. When the public health emergency ended in 2023, most state programs kept the telehealth allowance. Six years on, telehealth certification is the dominant model in most medical-cannabis states, with one notable holdout (Florida) and a handful of patient-category exceptions.
This article maps the state rules, the federal framework that governs controlled-substance prescribing via telehealth, the payment models patients should expect, and the questions worth asking before choosing a telehealth provider.
The federal framework: Ryan Haight Act and the COVID extensions
Telehealth prescribing of controlled substances is governed at the federal level by the Ryan Haight Online Pharmacy Consumer Protection Act of 2008. The Act generally prohibits prescribing controlled substances without an initial in-person examination, with narrow exceptions for telemedicine conducted with the patient in a hospital or clinic in the presence of another practitioner.
This created an obvious problem when the March 2020 COVID public health emergency forced the entire US health system into telemedicine. The DEA and HHS issued emergency rules waiving the in-person requirement for Schedule II–V controlled-substance prescribing. Those flexibilities have been extended four times, most recently through December 31, 2026 by a December 2025 rule.
Two important points for medical cannabis specifically:
- State medical cannabis certification is not federal controlled-substance prescribing. Even pre-April 2026 rescheduling, state medical-cannabis programs operated through "certification" or "recommendation" mechanisms that are distinct from DEA-registered controlled-substance prescribing. The Ryan Haight Act framework technically does not directly govern state medical-cannabis certification.
- The federal telemedicine flexibility was nevertheless influential. Many state programs adopted telehealth-certification rules during 2020–2021 specifically in response to the federal emergency posture, even though state programs operate on parallel state authority. When the federal flexibilities have continued, so have the state telehealth rules.
The April 22, 2026 Schedule III order does not modify the Ryan Haight Act framework for state medical-cannabis certification. State programs continue to operate under state authority.
States that fully allow telehealth for initial and renewal certifications
Most US medical-cannabis states allow audio-video telehealth for both initial and renewal certifications. The list includes (non-exhaustive):
- New York — full telehealth via phone call or video chat. Certification validity has moved to two years as of March 2026.
- Pennsylvania — telehealth permitted for both initial and renewal certifications by registered practitioners.
- Maryland — telehealth permitted.
- Ohio — telehealth permitted.
- Massachusetts — telehealth permitted.
- Illinois — telehealth permitted.
- Connecticut — telehealth permitted.
- Missouri — telehealth permitted.
- Oklahoma — telehealth permitted (the program is generally one of the most permissive in the US for certification mechanics).
- Most newer programs (Kentucky, West Virginia, Virginia, others) — telehealth permitted under varying degrees of state-specific documentation requirements.
The general pattern: a registered practitioner conducts an audio-video evaluation, reviews any relevant medical records the patient provides, and issues the state-required written certification. The patient then completes the state-program application through the state's online portal.
States with in-person initial requirements
The most prominent exception is Florida, which requires an in-person initial evaluation by a qualified Florida-licensed physician. Telehealth is permitted for subsequent renewals once the initial in-person relationship is established. The Florida rule reflects the state's deliberately conservative regulatory posture on its 800,000+ patient program; the Department of Health has not moved to relax the initial in-person requirement post-COVID.
A handful of other states maintain in-person initial requirements for specific patient categories:
- Minor patients — many states require at least one in-person evaluation for pediatric certifications, even where adult certification is telehealth-eligible. This reflects the additional clinical-judgment standard most states apply to pediatric medical-cannabis decisions.
- First-time patients in specific conditions — a few states (Louisiana historically; some others) have rules requiring in-person evaluation for chronic-pain or PTSD certifications specifically.
- Certifications by practitioners who do not have an established physician-patient relationship — some states require evidence of prior or ongoing primary-care relationship; "first-time telehealth visit from a cannabis-certification-only clinic" may not satisfy state rules.
How telehealth certification typically works
The process, in five steps:
Step 1: Choose a registered telehealth provider
State regulators publish lists of registered certifying practitioners. Patients should:
- Verify the practitioner is registered with the state's medical-cannabis program (not just licensed to practice in general).
- Confirm the practitioner offers telehealth visits (not all do).
- Compare visit fees across providers ($75 to $250 is typical).
- Check patient reviews for the provider's specific clinic.
Some telehealth platforms specialize in medical-cannabis certification (Leafwell, NuggMD, Marijuana Doctor, ELEVATE, others). These platforms typically offer a network of registered practitioners across multiple states; the patient pays a platform fee plus a practitioner fee.
Step 2: Schedule a visit
Many telehealth providers offer same-day or next-day appointment availability. Patients should:
- Confirm whether they will be evaluated by a physician, nurse practitioner, or physician assistant (state programs vary in which credentials may certify).
- Confirm the visit format (video required in some states; audio-only acceptable in others).
- Prepare any medical records relevant to the qualifying condition for upload before the visit.
Step 3: Conduct the visit
A typical telehealth certification visit lasts 10 to 30 minutes. The practitioner:
- Verifies the patient's identity and state residency.
- Reviews the patient's medical history and the condition for which certification is sought.
- Evaluates whether the patient has a qualifying condition under state law.
- Discusses treatment expectations, product options, and reasonable patient education.
- Issues the certification if the evaluation supports it.
Patients should be prepared to articulate their condition, the relevant medical history, what conventional treatments have been attempted, and why medical cannabis is being considered. Practitioners are required by state regulators to make a clinical judgment about whether cannabis is reasonable — not simply approve any patient who pays the visit fee.
Step 4: Receive the certification
The certification is typically delivered electronically (PDF or direct submission to the state's online portal) within hours to a few days of the visit. Patients should:
- Confirm the certification reaches the state program (some platforms handle the state-portal upload; others require the patient to upload).
- Save a copy for personal records.
- Pay any outstanding fees promptly to avoid hold-ups in state-program approval.
Step 5: Complete the state-program application
The state application is generally a separate step from the practitioner certification. Most state programs use an online portal where the patient:
- Creates an account with their identity verification.
- Uploads proof of state residency.
- Uploads the practitioner certification.
- Pays the state application fee.
State approval timelines range from same-day (Oklahoma, Missouri) to 7–14 days (most comprehensive medical programs) to longer for applications flagged for documentation review.
Payment models patients should expect
Three common payment structures:
Practitioner-direct payment
The patient pays the certifying practitioner (or telehealth platform) directly. State application fees are separate, paid to the state. Total cost ranges from $100 to $400 depending on state, practitioner, and any included extras (renewal-reminder services, patient-rights information, dispensary-discount partnerships).
Subscription / membership models
Some telehealth platforms offer subscription pricing: a monthly or annual fee includes the certification visit, renewal visits, ongoing patient-rights support, and (in some cases) discounts at partner dispensaries. The math works for patients who anticipate using cannabis regularly; the calculation is less favorable for patients who anticipate a single annual renewal cycle.
Bundled platform pricing
Some platforms bundle the practitioner visit, the state-application processing, and (in some cases) follow-up communication into a single upfront fee. The transparency varies; patients should confirm exactly what is included before paying.
Insurance coverage: insurance generally does not cover medical-cannabis certification visits, because the visit's primary purpose is medical-cannabis certification rather than a covered medical-care procedure. Some HSA / FSA programs may reimburse the practitioner fee as a qualified medical expense, but this is plan-specific.
Questions to ask before choosing a telehealth provider
Six questions worth answering before paying for a telehealth certification visit:
- Is the practitioner registered with my state's medical-cannabis program? Verify against the state regulator's published list, not the platform's marketing.
- Does my state accept telehealth for initial certification? Florida and a few others do not.
- What is the total cost (practitioner fee + state application fee)? Get the all-in number before paying anything.
- Will I be evaluated by a physician, NP, or PA? State programs vary in which credentials can certify; some patients prefer specific credentials.
- What happens if I am denied certification? Many providers refund the visit fee if the patient does not meet qualifying-condition criteria; others do not.
- What ongoing support is included? Renewal reminders, dispensary navigation help, patient-rights questions: some providers include this; others charge separately.
What telehealth certification does not provide
A medical-cannabis telehealth certification does not include:
- A pharmacy-dispensed prescription. The patient still purchases from licensed state dispensaries, not from retail pharmacies.
- Drug-drug interaction screening with the patient's other medications. Some certifying practitioners do this thoroughly; others do not. Patients on multiple medications should specifically request interaction review.
- Primary care. The certifying practitioner generally is not the patient's primary care physician. Patients should continue their primary care relationships and ensure their primary physician knows about the medical-cannabis use.
- Federal employment, security-clearance, or DOT-regulated transportation protection. See the companion article on federal employment.
- Out-of-state reciprocity. A telehealth-issued state certification is valid only in the issuing state. See the reciprocity article for the cross-state rules.
The 2026 outlook
Two developments worth tracking through the rest of 2026:
- The December 31, 2026 telemedicine flexibility expiration. The DEA / HHS extension of COVID-era telemedicine flexibilities for Schedule II–V controlled-substance prescribing expires at year-end unless extended a fifth time or replaced with permanent rulemaking. The DEA's proposed "Special Registration for Telemedicine" framework, if finalized, would provide a permanent pathway. State medical-cannabis certification is largely independent of this federal framework, but practitioners certifying patients in states where the certification process is functionally telehealth-equivalent watch this rule closely.
- State-level rule reviews post-Schedule III. A few state programs have indicated they will revisit certification rules post-rescheduling. Whether any state moves toward requiring in-person evaluation (in response to rescheduling-prompted "more medical" framing) or moves further toward telehealth (responding to patient demand) is state-specific. For now, the May 2026 baseline holds.
For most patients in most states, telehealth medical-cannabis certification is the dominant and cheapest pathway to a state card. The exceptions are well-documented (Florida, minor patients in some states, specific condition categories in a few states), and the federal framework is stable through year-end.
[Last reviewed 2026-05-18. This is informational only — not medical or legal advice. Verify telehealth certification rules with your state's medical-cannabis program before booking a visit.]
Sources
- NORML: State Laws indexaccessed May 18, 2026
- NCSL: Cannabis Overviewaccessed May 18, 2026
- New York Office of Cannabis Management: Patient Resourcesaccessed May 18, 2026
- Florida Office of Medical Marijuana Use (OMMU)accessed May 18, 2026
- Federal Register: Fourth Temporary Extension of COVID-19 Telemedicine Flexibilities (December 31, 2025)accessed May 18, 2026
- HHS: DEA Telemedicine Extension Through 2026 (December 2025)accessed May 18, 2026
- Pennsylvania Department of Health: Medical Marijuana Patientsaccessed May 18, 2026